Recent News:

May 2, 2022
The CF Foundation is now accepting applications for the Biological Basis for Cystic Fibrosis Related Diabetes (CFRD) RFA.  
This RFA was developed to begin addressing some of the research gaps/needs identified during the 2021 CFF/NIDDK CF-Related Diabetes Sceintific Workshop. The primary goal of this funding opportunity is to support projects that will improve our understanding of the biological underpinnings of the development and progression of CFRS, and/or serve to identify potential novel therapeutic strategies to manage and treat the disease. 
Applicants may request up to $150,000 per year (plus 12% indirect costs) for up to 3 years to complete the proposed projects. The deadline to apply for the 2022 cycle is August 2, 2022.  

February 23, 2022
Ohio State University's department of Microbial Infection and Immunity present Dan Wozniak with The Distinguished Scholar Award. 
Recipient: Dan Wozniak, PhD
Dr. Wozniak is affiliated with the Ohio State University.

January 26, 2022
Nationwide Children's Hospital Researcher Lauren Bakaletz, PhD, Honored by AAAS as Lifetime AAAS Fellow.
The American Association for the Advancement of Science (AAAS) has elected Lauren Bakaletz, PhD, to the newest class of AAAS Fellows, among the most distinct honors within the scientific community.  

November 17, 2021
Invention Patent: Respiratory Syncytial Virus Having Altered NS1 Protein Function and related Materials and Methods
Inventors: Peeples, M.E., Teng, M., Ramilo, O., Mejias, M.A., Flano, E
Drs. Ramilo and Mejias are affiliated with Nationwide Children's Hospital. Dr. Teng is affiliated with University of South Florida and Dr. Flano is currently affiliated with Boehringer Ingelheim. 

September 2021
CF Foundation First/Second Year Clinical Fellowship Grant Awarded
Recipient:  Rachel Ronau

August 2021
CF Foundation Award 
Principle Investigator:  Matthew Long
Application Title:  Anti-Bacterial and Anti-Inflammatory Strategies for CF Lung Disease

April 2021
CF Foundation Pilot and Feasibility Grant Awarded 
Principle Investigator:  Yizhou Dong
Application Title:  Engineered Macrophages for Treating Lung Infections in Cystic Fibrosis

February 2021
​​Voices of Excellence from Arts and Sciences
What makes us sick? Daniel Wozniak looks at the causes

November 2020
​​Eleven Ohio State scientists named AAAS Fellows
Congratulations to AAAS Fellow, Dan Wozniak!

August 2019
Cystic Fibrosis Research and Development Program Awarded $2 Million Grant From Cystic Fibrosis Foundation

Upcoming Events

Full Event Schedule

Core Services

C3 is organized around three biomedical research cores that support ongoing research projects.

Epithelial Cell

Immune

Translational

Grant Opportunities

C3 Training Grant Award:
Grant Application Deadline: 
February 27th at 5pm

C3 Pilot & Feasibility Award:
Grant Application Deadline: 
February 27th at 5pm

View More

Our Research

C3 researchers have many exciting collaborative projects aimed at understanding the interplay of host immunity, infection, and inflammation in persons with CF.

Members

Publications

Karen McCoy, MD​

Program Co-Director
​Nationwide Children's Hospital
Email

Daniel Wozniak, PhD​

Program Co-Director
​The Ohio State University
Email